Join us in the Big Apple for VEE 2023

TearCare®, precise heat, superior clearing1, long-term alternative.

Come find us at VEE, New York, Booth #F2808 for a demo of the TearCare® System.

Ask us about our Show Special!

Request a call from a Rep.

The TearCare® System:

The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.

TEARCARE SmartLids®

  • Optimal targeted heat
    • 41° to 45°C for up to 15 minutes
  • Open–eye design for natural blinking
  • Universal fit

TEARCARE SmartHub™

  • Highly Portable
  • Brainpower behind consistent heat
  • Monitors temperature 240x per second

Clearance Assistant™

  • Meibomian gland expression
  • Real-time visualization
  • Precise gland targeting

Reference

1. Holland EJ, Loh J, Bloomenstein M, Thompson V, Wirta D, Dhamdhere K. A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease. Clin Ophthalmol. 2022;16:2861-2871. Published 2022 Aug 30. doi:10.2147/OPTH.S368319

Indications for Use: The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands. 
The TearCare® System may not be right for everyone. Please see Instructions for Use or visit TearCare.com for Contraindications, Warnings, Precautions and Adverse Events.

SightSciences_Logo_White_2410x880
  • 4040 Campbell Ave, Suite 100
  • Menlo Park CA 94025
  • T: 877-266-1144

© 2023 Sight Sciences, Inc.      1/23     TC-2275-US.v2     TearCare, the TearCare logo, Sight Sciences, the Sight Sciences logo, SmartLids, Clearance Assistant, SmartHub are trademarks
or registered trademarks of Sight Sciences.